'Isoniazid' diaporamas de présentation

Seizures

Seizures. Esmailian Mehrdad MD Faculty Member of Esfahan University. Terminology. Seizures: an episode of neurologic dysfunction caused by abnormal neuronal activity that results in a sudden change in behavior, sensory perception, or motor activity

979 views • 70 slides

Psychopharmacology and General Medical Conditions

Psychopharmacology and General Medical Conditions. David A Fohrman, M.D. Question. What percent of your patients with psychiatric complaints have a General Medical Condition (GMC)/and or drug interaction that is causing or exacerbating his or her symptoms? A: 30% B: < 1% C: 60% D: 22%

740 views • 57 slides

Psychopharmacology and General Medical Conditions

Psychopharmacology and General Medical Conditions. David A Fohrman, M.D. Question. What percent of your patients with psychiatric complaints have a General Medical Condition (GMC)/and or drug interaction that is causing or exacerbating his or her symptoms? A: 30% B: < 1% C: 60% D: 22%

811 views • 57 slides

Foundations in Microbiology

990 views • 50 slides

Drug Resistant Tuberculosis (DR-TB): An Update

Drug Resistant Tuberculosis (DR-TB): An Update . Dr. Dick Menzies Montreal Chest Institute. Definitions. Primary DR: Resistance in person treated <1 month or not at all Acquired DR: Resistance in person treated > 1 month Mono-drug resistance: Resistance to 1 drug

957 views • 49 slides

Mycobacteria

Mycobacteria. A. Characteristics . I. Slowly growing organism; making them relatively resistant to antibiotics II. Mycobacterial cells can also be dormant and thus completely resistant to many drugs III. Lipid rich mycobacterial cell wall is impermeable to many agents

731 views • 47 slides

561 views • 44 slides

Mycobacterium

Mycobacterium. Filename: Myco.ppt. Outline. Microbial characteristics Diseases Tuberculosis Leprosy Treatment Prevention. Mycobacterium. Mycobacteriaceae are represented by the single genus Mycobacterium Closely related to the genera Corynebacterium and Nocardia. Rhodococcus

785 views • 41 slides

Tuberculosis Drug Issues: Fixed Dose Combination Products Second Line Drugs, and Prices,

Tuberculosis Drug Issues: Fixed Dose Combination Products Second Line Drugs, and Prices,. Richard Laing, Kelly McGoldrick Boston University School of Public Health. Overview of TB Drug Issues. Since streptomycin became available in 1948 drugs have become the mainstay of TB control

631 views • 29 slides

Isoniazid

Isoniazid. Seizure Glutamic acid decarboxylase Coenzyme pyridoxamine No GABA formed AG metabolic acidosis Blocks conversion of lactate to pyruvate Hyperglycemia. 22 y/o male asthmatic took some pills to kill himself and is comatose. BP 120/80 HR 110 RR 20 T 101 Wheezing 7.36/22/250.

792 views • 28 slides

Mutant Prevention Concentration and the Selection Window Hypothesis Karl Drlica, Xilin Zhao, and Tao Lu Public Health

629 views • 27 slides

Chapter 20, part A

Chapter 20, part A. Antimicrobial Drugs. Antimicrobial Drugs. Chemotherapy The use of drugs to treat a disease Antimicrobial drugs Interfere with the growth of microbes within a host Antibiotic Substance produced by a microbe that, in small amounts, inhibits another microbe

411 views • 26 slides

Selection of TB Medicines and Supplies

Selection of TB Medicines and Supplies. Unit Objective. Understand basic principles of selection of appropriate formulations of essential tuberculosis medicines . QUAN 1. Selection. Management. Procurement. Use. Support. Distribution. Policy and Legal Framework.

350 views • 22 slides

Deficiencies in Bioequivalence dossiers

Deficiencies in Bioequivalence dossiers. Overview and Examples . Summary of Submissions for Tuberculosis-Drugs. 2- FDC (R, H) 29 Pyrazinamide (Z) 19 Ethambutol (E) 18 Isoniazid (H) 16 4-FDC (R,H,Z,E) 13 Rifampicin (R) 12 3-FDC 8.

436 views • 21 slides

European Toxicology From a National Toxicology Program Perspective

European Toxicology From a National Toxicology Program Perspective Dr. Christopher J. Portier Associate Director, National Toxicology Program Director, Environmental Toxicology Program National Institute of Environmental Health Sciences Department of Health and Human Services

544 views • 20 slides

Ch 20: Antimicrobial Drugs

Ch 20: Antimicrobial Drugs. Chemotherapy The use of drugs to treat a disease Antimicrobial drugs Interfere with the growth of microbes within a host Antibiotic Substance produced by a microbe that, in small amounts, inhibits another microbe

469 views • 19 slides

Module 3: Drug-Resistant TB

Module 3: Drug-Resistant TB. Learning Objectives. Describe how drug resistance emerges Explain the difference between primary and secondary resistance Explain indications for drug susceptibility testing Name 6 ways to prevent MDR TB. Types of TB Resistance.

374 views • 18 slides

axali TB preparatebi , axali samkurnalo reJimebi : gza TB mkurnalobis gaumjobesebisaken

axali TB preparatebi , axali samkurnalo reJimebi : gza TB mkurnalobis gaumjobesebisaken. neli solomonia ; samecniero seminari ; 24.11.09. axali TB samkurnalo reJimebi : ra sWirdebaT qveynebs ? agvisto ; 2009 sensitiuri tuberkulozis ukve arsebuli da axali samkurnalo reJimebis Sefaseba.

515 views • 17 slides

Tuberculosis

816 views • 15 slides

TB infection control in the era of MDR and XDR TB

TB infection control in the era of MDR and XDR TB. Haileyesus Getahun Stop TB Department WHO/HQ. Collaborative TB/HIV activities . A. Establish the mechanism for collaboration A.1. TB/HIV coordinating bodies A.2. HIV surveillance among TB patient A.3. TB/HIV planning

351 views • 9 slides